Fetuin-A as Metabolic Biomarker in Patients at Higher Risk of Heart Failure
AA Berezin, VA Poliasnyi… - Journal of …, 2021 - jbiochemtech.com
Heart failure (HF) demonstrates an epidemic-shaped growth worldwide and continues to be
a staggering health problem regardless of unprecedented efforts in diagnosis and treatment …
a staggering health problem regardless of unprecedented efforts in diagnosis and treatment …
Specifics of fetuin‐A levels in distinct types of chronic heart failure
M Lichtenauer, B Wernly, V Paar, I Rohm… - Journal of clinical …, 2018 - Wiley Online Library
Introduction Fetuin‐A has been described to correlate inversely with vascular calcification
both in animal models but also in patients with heart and renal disease. In this current study …
both in animal models but also in patients with heart and renal disease. In this current study …
Serum fetuin-A levels in patients with systolic heart failure
Objective Inflammation and dystrophic calcification have been associated with
cardiovascular disease (CVD) and chronic heart failure (CHF). The aim of the present study …
cardiovascular disease (CVD) and chronic heart failure (CHF). The aim of the present study …
Fetuin-A and the cardiovascular system
K Mori, M Emoto, M Inaba - Advances in clinical chemistry, 2012 - books.google.com
Fetuin was first isolated from bovine serum in 1944. It is now most commonly known as
either fetuin-A or alpha-2-HS-glycoprotein (AHSG), the protein product of Ahsg gene. A …
either fetuin-A or alpha-2-HS-glycoprotein (AHSG), the protein product of Ahsg gene. A …
[PDF][PDF] Fetuin-A (AHSG) and its usefulness in clinical practice. Review of the literature
AM Dabrowska, JS Tarach… - Biomed Pap Med …, 2015 - biomed.papers.upol.cz
Background. Fetuin-A, also called Alpha 2-Heremans Schmid Glycoprotein, is a
multifunctional plasma agent what has been proven in animal and human studies. It plays a …
multifunctional plasma agent what has been proven in animal and human studies. It plays a …
Role of fetuin-A in atherosclerosis associated with diabetic patients
Objectives Fetuin-A is a circulating glycoprotein, formed in the liver. It regulates bone
remodelling and calcium metabolism. Fetuin-A has adipogenic properties, so fat …
remodelling and calcium metabolism. Fetuin-A has adipogenic properties, so fat …
Preanalytical study of fetuin-A: effect of sample type, processing speed and freeze–thaw cycles
L McArthur, L Johnston, N Sattar… - Annals of Clinical …, 2015 - journals.sagepub.com
Background It has been suggested that fetuin-A may be a potential biomarker of
cardiometabolic disease. However, few studies have investigated preanalytical factors that …
cardiometabolic disease. However, few studies have investigated preanalytical factors that …
[HTML][HTML] Evaluation of the correlation between fetuin-B levels and essential hypertension: a cross-sectional study
T Gao, R Liu, C Li, X Chu, Q Guo… - Endocrine …, 2023 - ec.bioscientifica.com
Background Fetuin-B, a cytokine that regulates lipid metabolism, has recently been linked to
cardiovascular diseases such as coronary heart disease. In this study, we discussed the …
cardiovascular diseases such as coronary heart disease. In this study, we discussed the …
Clinical implications of fetuin-A
P Jirak, L Stechemesser, E Moré, M Franzen… - Advances in clinical …, 2019 - Elsevier
Fetuin-A, also termed alpha2-Heremans-Schmid glycoprotein, is a 46 kDa hepatocyte
derived protein (hepatokine) and serves multifaceted functions.(i) It acts as systemic inhibitor …
derived protein (hepatokine) and serves multifaceted functions.(i) It acts as systemic inhibitor …
Serum Fetuin‐B Levels Are Elevated in Women with Metabolic Syndrome and Associated with Increased Oxidative Stress
S Xue, H Han, S Rui, M Yang, Y Huang… - Oxidative medicine …, 2021 - Wiley Online Library
Previous studies on serum fetuin‐B (fetuin‐like protein IRL685) have investigated its
association with T2DM; however, the reason for the variation in serum fetuin‐B and its …
association with T2DM; however, the reason for the variation in serum fetuin‐B and its …